CARDINAL HEALTH INC
For the period ended Sep 30, 2025. Filed Oct 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 30, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Other
Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
| Period | Total Numberof SharesPurchased (1,2) | Average Price Paid per Share(2) | Total Number of SharesPurchasedas Part of Publicly Announced Programs (2,3) | ApproximateDollar Value ofShares That MayYet be PurchasedUnder the Program (3)(in millions) |
|---|---|---|---|---|
| July 2025 | 11 | $159.70 | — | $2,743 |
| Aug 2025 | 2,025,391 | 148.12 | 2,025,385 | 2,443 |
| Sept 2025 | 31 | 150.34 | — | 2,443 |
| Total | 2,025,433 | $148.12 | 2,025,385 | $2,443 |
(1)Reflects 11, 6, and 31 common shares purchased in July, August, and September 2025, respectively, through a rabbi trust as investments of participants in our Deferred Compensation Plan.
(2)On August 13, 2025, we entered into an ASR program to purchase common shares for an aggregate purchase price of $375 million and received an initial delivery of 2.0 million common shares using a reference price of $148.12. The ASR program will conclude by October 31, 2025. See Note 10 of the "Notes to Condensed Consolidated Financial Statements" for additional information.
(3)On June 7, 2023, our Board of Directors approved a new $3.5 billion share repurchase program, which will expire on December 31, 2027. As of September 30, 2025, we had $2.4 billion authorized for share repurchases remaining under this program. The ASR program is expected to reduce the amount remaining under our existing share repurchase authorization to less than $2.4 billion when concluded.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.